Member Info for TrekMadone

This is a strategic vid, posted by Hydrogen on PUR. Even if you skip to 30mins it explains why you should invested in a few quality junior explorers. The data is awesome and he doesn’t even mention basel 3!

https://youtu.be/1UHAMvMjg5g

Enjoy!

Trek

It’s just the start. This is a strategic vid, posted by Hydrogen on PUR. Even if you skip to 30mins it explains why you should invested in a few junior explorers. The data is awesome and he doesn’t even mention basel 3!

https://youtu.be/1UHAMvMjg5g

Enjoy!

Trek

I think it was viewed as a holding rns by the market. Therefore put folk off as they figured it will now be a long wait for news.

Well I waited for the rns spike to pass and bought back in over the last few sessions.

As a returning investor it was a pretty easy decision at this price and just a research top up needed.

I didn’t expect to be able to time a 10p entry which I now see as excellent value with what’s to come.

Atb

Trek

The SP is in a trading range as imo some earlier investors sell half on a double.

There will be a step up in anticodon regs. Once the EP and drilling regs come through then another leg. Then securing drill, spud etc.

I’m in at 7.8 and 8.2. Sure you may get in lower. That’s what makes a market. However, park whether or not they find He. This is financed to drill. Those steps should come about. The sp should be higher as a result. That may give investors a chance of a free carry.

If they then strike commercial He, which I think is very likely the SP will rocket!

As for further finance, development etc they have been pretty clear. It’s for sale!

Usual caveats

Trek

Use the fill or kill option. Set your price for one day only. It will then sit in the order queue

Trek

Sssh. Imo This is an easy 10 bagger in the making. It’s one of the homes I found for my ARB profits. I expect a significant rerate on run up to H2 results. A very unique cashed up niche opportunity pushing against a worldwide open door!

Still buying!

Trek

And now it’s just been removed from my profile!

Don’t be under any illusions that these bb’s are not heavily surveyed.

Trek

Well i’m not going mad. My post at 7:43 on the ARB bb has been removed but you can see it on my pie/profile.

I suspect they get parked, probably key words and then released back to the bb once vetted.

It follows some of the links I published here that are in the public domain about some of the covid drugs efficacy. Those were removed but I noticed other posts disappeared then reappeared and now I saw a live example to validate my sanity!

Xyz,

I saw your reply. I hope you are well my virtual friend.

Trek

Out the way at last and minimal dilution. Not that I expect em to be sold with the impending newsflow but if the wish it will add liquidity.

https://www.londonstockexchange.com/news-article/GRL/settlement-of-claim-by-former-director/14829745

Trek

You may get a different second dose!

“Previous incomplete vaccination.

If the course is interrupted or delayed, it should be resumed using the same vaccine but the first dose should not be repeated. There is no evidence on the interchangeability of the COVID-19 vaccines although studies are underway. Therefore, every effort should be made to determine which vaccine the individual received and to complete with the same vaccine. For individuals who started the schedule and who attend for vaccination at a site where the same vaccine is not available, or if the first product received is unknown, it is reasonable to offer one dose of the locally available product to complete the schedule. This option is preferred if the individual is likely to be at immediate high risk or is considered unlikely to attend again. In these circumstances, as both the vaccines are based on the spike protein, it is likely the second dose will help to boost the response to the first dose. For this reason, until additional information becomes available, further doses would not then be required.”

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/948757/Greenbook_chapter_14a_v4.pdf

Trek

A closer comparison.....

“After all, the results at Fosterville have been stunning.
By the end of 2019, the mine’s owner, Kirkland Lake Gold (TSX:KL) (NYSE:KL), reported high-grade gold reserves of 2 million ounces with an additional 1.7 million inferred ounces at the site.
Better yet, between 2017 and 2019, the company mined 1.2 million ounces at Fosterville for a cost of just $315 an ounce, and an incredible average grade of 30.6 grams a tonne!
The Fosterville Gold Mine comfortably leads the pack when it comes to the world’s highest-grade, lowest-cost mining operations.
With such phenomenal success, it is no surprise that Kirkland Lake’s share price shot up over 27 TIMES, from C$2.20 in July 2015 to more than C$60 by the end of last year.
This has transformed the miner into a C$15 billion firm....”

““Victoria has hardly scratched the surface when it comes to exploring these newly identified, high-grade underground gold zones.
There has been a lot of exploration done at Ballarat and Bendigo as they are very big goldfields, but when you look in a regional sense, there are very few deep drill holes.
Even on our ground in Lauriston, which sits directly adjacent to the Fosterville Gold Mine, there are only about a dozen reverse circulation holes and half a dozen diamond holes
None of these have gone deeper than about 200m in terms of drilling. For an area that is 600km2 in size that is minuscule. With such high-grade, near-surface historic production here, that is extremely surprising, but it also opens up an incredible opportunity for Fosterville South “

Or for that matter the DMS.

https://www.valuethemarkets.com/2020/04/27/report-fosterville-south-exploration-pursuing-a-new-frontier-in-high-grade-gold-exploration/

Trek

Relatively few shares here. A decent NexTech update and we will rerate to £4 in a blink. That’s the issue with these shares you sit here for years, you get loads of news and it’s not in the price then suddenly over a couple of sessions it rerates!

250-300 mcap is not unreasonable for us given we are ebitda positive and growing rapidly.

Usual caveats

Trek

Ha Saxon,

I made a similar post a few days ago and included the links re the fatalities! It was removed!

Must go there’s someone at the door!

Trek

Most trades are buys at 2.90 today. Sums it up! Gonna go higher eventually but only once CG are ready!

It can often really work in an investor’s favour when the MM is the broker. We have an aligned interest. They wanna create liquidity and profit, and if a PI, like Trek spots said opportunity then it’s ‘easy’ money!

But then no one will believe a word I say so it’s back to the enigma!

Trek

It’s down 5p it was never 300p. MM/broker got full control of this book!

Trek

“ The level of disclosed Short Interest in SNG has changed materially.

Short Interest has moved from 0% on the previous trading day to 0.51% today. That is a movement of 0.51 percentage points.

Click here to see the full detail broken down by fund

This data is taken from the FCA and comprises all disclosed short positions above the 0.5% reporting threshold requirement.”

lol! I expect it’s to underwrite a physical position.

Trek

Well this is worrisome given the pace of mutation it may not be long before there is an escape mutation. Should probably save the post for the w/e really.....

“A distinct strain of SARS-CoV-2 emerges in the UK recently, reportedly accounting for over 60% new infections in the London area. CDC also names the variant "SARS-CoV-2 VOC (variant of concern) 202012/01", highlighting its clinical significance.

The newly identified lineage B.1.1.7 carries an unusually high number of genetic mutations, resulting in an unprecedented 14 AA replacement. Eight of these mutations occur in the spike protein and the following three are particularly worrisome.
-- N501Y, which reportedly leads to an increased binding affinity to human and murine ACE2 receptors
-- 69-70del, which arose from the outbreak linked to farmed minks
-- P681H, which is closed to the furin cleavage site.

It's also important to monitor the B.1.1.7 strain together with the previously identified high frequency variants, such as
-- D614G, which may cause a moderately increased transmissibility
-- N439K, which may be an "escape mutant" for some neutralizing antibodies
-- Y453F, which may be an "escape mutant" for some neutralizing antibodies.

Sino Biological has produced a collection of recombinant antigens for these variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.......”

https://www.sinobiological.com/research/virus/sars-cov-2-spike-mutation?utm_source=newsmedical-id&utm_medium=etoc&utm_campaign=jan-ncov-n501y

Trek

Well this is worrisome given the pace of mutation it may not be long before there is an escape mutation. Should probably save the post for the w/e really.....

“A distinct strain of SARS-CoV-2 emerges in the UK recently, reportedly accounting for over 60% new infections in the London area. CDC also names the variant "SARS-CoV-2 VOC (variant of concern) 202012/01", highlighting its clinical significance.

The newly identified lineage B.1.1.7 carries an unusually high number of genetic mutations, resulting in an unprecedented 14 AA replacement. Eight of these mutations occur in the spike protein and the following three are particularly worrisome.
-- N501Y, which reportedly leads to an increased binding affinity to human and murine ACE2 receptors
-- 69-70del, which arose from the outbreak linked to farmed minks
-- P681H, which is closed to the furin cleavage site.

It's also important to monitor the B.1.1.7 strain together with the previously identified high frequency variants, such as
-- D614G, which may cause a moderately increased transmissibility
-- N439K, which may be an "escape mutant" for some neutralizing antibodies
-- Y453F, which may be an "escape mutant" for some neutralizing antibodies.

Sino Biological has produced a collection of recombinant antigens for these variants. The reagents can be used to evaluate the efficacy of the antibodies and vaccination.......”

https://www.sinobiological.com/research/virus/sars-cov-2-spike-mutation?utm_source=newsmedical-id&utm_medium=etoc&utm_campaign=jan-ncov-n501y

Trek

Dear Trek,

ONCIMMUNE HOLDINGS PLC will be holding a Oncimmune Holdings PLC HY Results Group Meeting meeting on 15th Feb 2021 at 4:30pm GMT.

Please click on the button below to login and accept the meeting invitation.

Accept
Should you have any questions, please contact investorhelp@investormeetcompany.com.

Kind Regards,

The Team at Investor Meet Company

Agree, not much in this other than a ‘little pocket money’.

https://www.londonstockexchange.com/news-article/DCTA/exercise-of-options-and-director-pdmr-dealing/14827948

Trek